Form 4: Cross Country Healthcare Officer Granted Restricted Stock

Cross Country Healthcare's Chief Accounting Officer, James V. Redd III, received a grant of 12,311 restricted shares of common stock, vesting over three years.

Summary

• James V. Redd III, Chief Accounting Officer of Cross Country Healthcare Inc. (CCRN), acquired 12,311 shares of common stock.
• These shares are Restricted Stock Awards (RSAs) granted on December 18, 2025, with a transaction price of $0.
• The RSAs will vest in three substantially equal installments on December 18, 2026, March 31, 2027, and March 31, 2028.
• The grant date was adjusted from an originally planned March 31, 2025, to December 18, 2025.
• This adjustment followed the termination of a merger agreement with Aya Holdings II Inc., Spark Merger Sub One Inc., and Aya Healthcare, Inc. on December 3, 2025.
• Following this transaction, James V. Redd III beneficially owns a total of 31,110 shares of common stock.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The grant itself is a routine compensation event, aligning executive interests. However, the underlying reason for the adjusted grant date (terminated merger) introduces a degree of uncertainty or a missed strategic opportunity, which is a slight negative context.

Positives

• The grant of restricted stock to a key executive (Chief Accounting Officer) aligns management interests with long-term shareholder value.
• The multi-year vesting schedule encourages executive retention and sustained performance.

Risks

• The termination of the merger agreement with Aya Holdings II Inc., Spark Merger Sub One Inc., and Aya Healthcare, Inc. on December 3, 2025, could introduce strategic uncertainty or impact the company's future growth trajectory.

Future Outlook

The vesting schedule for the granted Restricted Stock Awards extends through March 31, 2028, aligning future executive incentives with long-term company performance. The company's Compensation Committee adjusted the grant date following the termination of a significant merger agreement, suggesting a recalibration of executive compensation strategy post-merger.

Management Comments

• The Compensation Committee of the Company's Board of Directors approved the number of RSAs to be granted on December 18, 2025, instead of March 31, 2025, following the termination of the Merger Agreement with Aya Holdings II Inc., Spark Merger Sub One Inc. and Aya Healthcare, Inc. on December 3, 2025.

Industry Context

The grant of restricted stock to a Chief Accounting Officer is a standard practice in the healthcare staffing industry for executive compensation, aiming to align management incentives with shareholder value. The mention of a terminated merger agreement with Aya Healthcare, Inc. suggests a significant strategic shift or missed opportunity for Cross Country Healthcare, potentially impacting its competitive positioning or growth trajectory within the healthcare services sector.

Comparison to Industry Standards

• The grant of restricted stock to a Chief Accounting Officer is a common executive compensation practice across various industries, including healthcare staffing.
• The vesting schedule over three years is typical for such awards, designed to promote long-term retention and performance alignment.
• While specific comparable companies or projects are not detailed in this filing, similar grants are observed at peers like AMN Healthcare Services (AMN) or HealthEquity (HQY) for their executives, often tied to performance metrics or time-based vesting.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant aligns the Chief Accounting Officer's interests with long-term shareholder value through equity ownership and a vesting schedule. The termination of the merger agreement, which led to the adjusted grant date, could have broader implications for shareholder value, though not directly detailed in this Form 4.
• Management: The Chief Accounting Officer receives additional equity compensation, incentivizing continued performance and retention.

Next Steps

• First vesting installment of RSAs on December 18, 2026.
• Second vesting installment of RSAs on March 31, 2027.
• Third vesting installment of RSAs on March 31, 2028.

Key Dates

Recommendation

This Form 4 filing details a routine executive compensation event, specifically a restricted stock grant to the Chief Accounting Officer. While it aligns management incentives with shareholder interests, it does not provide new information regarding the company's operational performance, financial health, or strategic direction beyond the previously announced merger termination. Therefore, it does not warrant a change in investment recommendation based solely on this filing. Investors should 'hold' and await further operational or financial updates.

Keywords

Cross Country Healthcare, CCRN, Form 4, Restricted Stock Award, RSA, Executive Compensation, Insider Transaction, James V. Redd III, Chief Accounting Officer, Merger Termination